Preview

FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology

Advanced search

Pharmacoepidemiological analysis of medication consumption in a multidepartmental hospital as an element of medical care quality management and the basis for assessing import substitution

https://doi.org/10.17749/2070-4909/farmakoekonomika.2022.046

Abstract

Objective: pharmacoepidemiological analysis of medication list used in a multidepartmental hospital.

Material and methods. The material for the analysis was the costs of medications for the reporting period of 2017–2018. We used the tools of ABC/VEN analysis and import substitution assessment. The assessment of import substitution in a medical organization was carried out in comparison of 2018 with 2017 by the change in costs for various pharmacotherapeutic groups of medications in two segments (domestic and foreign production) in percentage terms.

Results. The results of the analysis revealed, that the antibiotics are the largest volume of the cost structure for various pharmacotherapeutic groups: 18.8% in 2017 and 15.6% in 2018. The analysis of the medication list used in a medical organization, regarding to the production segment, showed that in 2017 22.6% was spent on domestic medications. In 2018, this indicator increased by 15.2% and amounted to 37.8%. The correct, regular distribution of groups V, E, N in groups A, B, C was revealed. More than 80% of group A consists of medications from group V of all monetary costs and the share of medication belonging to group N is less than 3%. In total, the cost of medications of groups V and E is more than 90%.

Conclusion. The use of these methods allows to optimize the costs of medications provision for therapeutic and diagnostic processes and to improve pharmaceutical diseases therapy. In 2018, compared to 2017, there is a redistribution of the cost structure for medications towards an increase in the share of Russian-made medications. Given the lower cost of Russian medications compared to imported analogues, this approach will allow in the future to save the money of medical organizations with no deterioration in the quality of treatment. 

About the Authors

O. V. Zhukova
Privolzhskiy Research Medical University
Russian Federation

PhD (Pharm.), Associate Professor, Head of the Department for Pharmaceutical Chemistry and Pharmacognosy, Faculty of Pharmacy, 

10/1 Minin and Pozharskiy Sq., Nizhniy Novgorod 603950



O. V. Ruina
Privolzhskiy Research Medical University; Privolzhskiy District Medical Center, Federal Medical and Biological Agency of Russia
Russian Federation

MD, PhD, Associate Professor, Chair of General and Clinical Pharmacology, 10/1 Minin and Pozharskiy Sq., Nizhniy Novgorod 603950;

Clinical Pharmacologist, 10/1 Minin and Pozharskiy Sq., Nizhniy Novgorod 603950



M. V. Khazov
Privolzhskiy District Medical Center, Federal Medical and Biological Agency of Russia
Russian Federation

MD, PhD, Deputy Director, 

10/1 Minin and Pozharskiy Sq., Nizhniy Novgorod 603950



T. M. Konyshkina
Privolzhskiy Research Medical University
Russian Federation

MD, PhD, Associate Professor, Chair of Pharmaceutical Chemistry and Pharmacognosy, 

10/1 Minin and Pozharskiy Sq., Nizhniy Novgorod 603950



E. A. Rodin
Privolzhskiy Research Medical University
Russian Federation

Student, 

10/1 Minin and Pozharskiy Sq., Nizhniy Novgorod 603950



D. K. Lipatov
Privolzhskiy Research Medical University
Russian Federation

Student, 

10/1 Minin and Pozharskiy Sq., Nizhniy Novgorod 603950



References

1. Eliseeva E.V., Maneeva E.S., Goncharova R.K., Kropotov A.V. Clinical and economic analysis as an instrument for harmonizing import substitution in the preferential segment of medicinal support. FARMAKOEKONOMIKA. Sovremennaya farmakoekonomika i farmakoepidemiologiya / FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2019; 12 (3): 210–20 (in Russ.). https://doi.org/10.17749/2070-4909.2019.12.3.210-220.

2. Order of the Ministry of Health of the Russian Federation of February 13, 2013 No. 66 “On the approval of the Strategy of Drug Supply to the Population of the Russian Federation for the period up to 2025 and its implementation plan”. Available at: https://www.garant.ru/products/ipo/prime/doc/70217532/ (in Russ.) (accessed 19.04.2020).

3. Frolov M.Yu., Baranova O.N., Shatalova O.V. ABC/VEN analysis methodology. Lekarstvennyy vestnik (Medicinal Bulletin). 2012; 6 (6): 3–6 (in Russ.).

4. Ruina O.V., Zhukova O.V., Khazov M.V., et al. Relationship consumption of antibiotics and local microbiota. Modern Problems of Science and Education. 2020; 1: 60 (in Russ.). https://doi.org/10.17513/spno.29488.

5. Ruina O.V., Konishkina T.M., Borisov V.I., et al. Local microbiological monitoring as a basis for rational procurement and consumption of antibacterial preparations in surgery. Modern Science: Actual Problems of Theory and Practice. Series: Natural and Technical Sciences. 2019; 5: 184–8 (in Russ.).

6. Savelyev V.S., Gelfand B.R., Yakovlev S.V. (Eds.) Strategy and tactics of the use of antimicrobial agents in medical institutions in Russia. Russian national guidelines. Мoscow; 2012: 92 pp. (in Russ.)

7. Eliseeva E.V., Gaynullina Yu.I., Geltser B.I. Quality management in the field of drug use. Vladivostok: Dalnauka; 2010: 180 pp. (in Russ.).

8. Grigorieva K.D. Drug import replacement is a perspective direction of the development of russian economy. Administrative Consulting. 2018; 5: 137–42 (in Russ.). https://doi.org/10.22394/1726-1139-2018-5-137-142.

9. Kostromin P.A. Import substitution of medicines in russia by volume, nomenclature and quality. Theory and Practice of Social Development. 2015; 9: 73–77 (in Russ.).

10. Siukaeva D.D., Narkevich I.A., Timchenko V.N., Nemyatyh O.D., Maslova N.A. Use of medications in children hospitalized with community-acquired pneumonia. FARMAKOEKONOMIKA. Sovremennaya farmakoekonomika i farmakoepidemiologiya / FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2018; 11 (3): 8–12 (in Russ.). https://doi.org/10.17749/2070-4909.2018.11.3-008-012.

11. Shapovalova M.A., Koretskaya L.R. ABC and VEN analysys of costs for medicine sand medical treatment costs patient. FARMAKOEKONOMIKA. Sovremennaya farmakoekonomika i farmakoepidemiologiya / FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2014; 7 (1): 19–21 (in Russ.).


Review

For citations:


Zhukova O.V., Ruina O.V., Khazov M.V., Konyshkina T.M., Rodin E.A., Lipatov D.K. Pharmacoepidemiological analysis of medication consumption in a multidepartmental hospital as an element of medical care quality management and the basis for assessing import substitution. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2022;15(1):51-58. (In Russ.) https://doi.org/10.17749/2070-4909/farmakoekonomika.2022.046

Views: 254


ISSN 2070-4909 (Print)
ISSN 2070-4933 (Online)